ArticleBMC palliative care2026
Healthcare professionals and relatives in shaping the preferred place of end-of-life care and death for patients with advanced cancer: the WhereToCare qualitative study.
Article in BMC palliative care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough most people in France wish to die at home, the majority of deaths still occur in hospitals. The choices of end-of-life care for patients with advanced cancer and how these preferences are shaped by interactions with relatives and healthcare professionals, remains poorly understood. This study aimed to explore how patients with advanced cancer develop and adjust these preferences, and to examine the roles of relatives, general practitioners, and oncologists in this process.
methodsWe conducted a single-centre longitudinal qualitative study at a French university hospital involving adults with advanced, incurable solid cancers. Participants were invited to take part in up to three semi-structured interviews conducted approximately one month apart. Interviews explored illness trajectory, preferences for place of end-of-life care and death, and discussions with relatives and healthcare professionals. Data were analyzed using thematic analysis.
resultsEleven patients with metastatic solid tumours receiving care at a French university hospital completed at least two interviews between January and November 2023. Findings showed that although relatives were a key source of emotional support, patients deliberately limited their involvement in end-of-life discussions to protect them, resulting in relational distancing. A second layer of isolation concerned general practitioners, who were rarely consulted and not perceived as relevant interlocutors for end-of-life issues due to limited involvement in cancer care. In contrast, oncologists were identified as the main medical references, but primarily as technical experts focused on disease management rather than as professionals to address existential or end-of-life concerns. Consequently, patients often lacked a clearly identified professional with whom to discuss end-of-life preferences, reflecting communicative and decisional isolation. The longitudinal design further showed that these preferences were not fixed but evolved over time, often without a stable interlocutor to support reflection and discussion. When available, palliative care teams, or participation in the research interviews themselves, partially mitigated this gap by offering a space for reflection.
conclusionEnd-of-life preferences among patients with advanced cancer are strongly shaped by concerns for relatives, which may lead to limitations in discussions and contributes to a sense of isolation, with no clearly identified professional responsible for addressing these issues. Earlier, more proactive multidisciplinary involvement may help create spaces for reflection and support the expression of patients' wishes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.